Nikitin E, Kislova M, Morozov D, Belyakova V, et al. Ibrutinib in combination with rituximab is highly effective in treatment of
chronic lymphocytic leukemia patients with steroid refractory and relapsed
autoimmune cytopenias. Leukemia 2023 May 18. doi: 10.1038/s41375-023-01891.
PMID: 37202442